APXT
Apex Treasury Corporation Class A
There isn't enough reported data to score APXT yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
APXT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
APXT's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like APXT.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
APXT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 50x | $10.21 | — |
| Cheap | 85x | $16.96 | +66% |
| Fair | 86x | $17.10 | +68% |
| Expensive | 108x | $21.52 | +111% |
Historical ranges are pointers, not guarantees.
APXT has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
APXT Forward outlook
There aren't enough analyst estimates for APXT to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
APXT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.20 | +$1.34 |
| Q2 2026 | $0.16 | +$1.29 |
| Q1 2026 | $0.12 | +$1.32 |
APXT has returned to profit: it earned $0.20 per share over the past year, after losing money the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over APXT in the latest year-over-year earnings comparison.
APXT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $114.7M | -60% |
APXT's revenue has slid since its 2024 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 13% | +5.5 points |
| Q1 2025 | 3.5% | +28 points |
| Q4 2024 | 7.2% | N/A |
| Q3 2024 | 8.6% | N/A |
| Q2 2024 | -2.7% | N/A |
| Q2 2021 | -24% | N/A |
APXT's operating margin was 13% last quarter, up 15 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over APXT in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
APXT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$211.7K | -$211.7K |
| Q2 2026 | -$23.4M | -228% |
| Q1 2026 | $23M | +$24M |
| Q4 2025 | $29M | -66% |
| Q3 2025 | $0 | -100% |
| Q2 2021 | -$243 | +$210.3K |
| Q1 2021 | -$358.1K | +$24.8K |
| Q2 2020 | -$210.5K | -$210.5K |
APXT has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
APXT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +33% | +11.5M shares |
| 1 year | +360% | +36M shares |
| 3 years | +3.1% | +1.4M shares |
APXT has 46M diluted shares, up 360% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $59.8M |
| Q1 2026 | $59.8M |
| Q4 2025 | — |
| Q2 2025 | $19M |
| Q1 2025 | $11.9M |
| Q4 2024 | $33.1M |
| Q3 2024 | $21.7M |
| Q2 2021 | — |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over APXT on shareholder dilution, with a more favorable share count trend.
APXT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -40.5x | Net Cash |
| Q1 2025 | -41.4x | Net Cash |
APXT has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like APXT.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
APXT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 75.7 | Overbought |
| Stochastic | 80.0 | Overbought |
APXT's weekly RSI is 76 (overbought) and its Stochastic is 80 (overbought).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
APXT PE vs Financial Services Sector
| Metric | APXT | Sector median | Relative |
|---|---|---|---|
| PE | 50x | 13x | 287% above |
| PE % | 0 | 12 | 12 pts below |
APXT is trading at 50x earnings, a 287% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over APXT on valuation relative to its sector.
APXT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.2 | 0.5% above |
| 20 week MA | $10.1 | 0.8% above |
| 50 week MA | $10.0 | 1.8% above |
APXT has stronger trend alignment. APXT is above 3 of 3 weekly averages versus MS above 3 of 5.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
APXT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $9.89 | $9.88 | -0.1% |
| 2026 YTD | $9.88 | $10.2 | +3.3% |
APXT has finished every year since 2025 lower, and it's up 3.3% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over APXT on returns for 2026, with the stronger performance.